BaffourRBermanJGarbJLRheeSWKaufmanJFriedmannP.Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose–response effect of basic fibroblast growth factor. J Vasc Surg1992; 16: 181–91.
6.
PuLQSnidermanADBrassardREnhanced revascularization of the ischemic limb by means of angiogenic therapy. Circulation1993; 88: 208–15.
7.
Yangisawa-MiwaAUchidaYNakamuraFSalvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science1992; 257: 1401–403.
8.
FerraraNHenzelWJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun1989; 161: 851–55.
9.
KeckPJHauserSDKriviGVascular permeability factor, an endothelial cell mitogen related to PDGF. Science1989; 246: 1309–42.
LeungDWCachianesGKuangWJGoeddelDVFerraraN.Vascular endothelial growth factor is a secreted angiogenic mitogen. Science1989; 246: 1306–309.
12.
de VriesCEscobedoJAUenoHHouckKGerraraNWilliamsLT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science1992; 255: 989–91.
13.
MillauerBWizigmann-VoosSSchnurchHHigh affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell1993; 72: 835–46.
14.
TermanBIDougher-VermozenMCarrionMEIdentification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun1992; 187: 1579–86.
15.
KlagsbrunMD'AmorePA. Regulators of angiogenesis. Annu Rev Physiol1991; 53: 217–39.
16.
ReidyMAGlowesAWSchwartzSM. Endothelial regeneration. V. inhibition of endothelial regrowth in arteries of rat and rabbit. Lab Invest1983; 49: 569–75.
17.
ConnGSodermanDSchaefferM-TWileMHatcherVBThomasKA. Purificationof glycoprotein vascular endothelial cell mitogen from a rat glioma cell line. Proc Natl Acad Sci USA1990; 87: 1323–27.
18.
ShenHClaussMRyanJCharacterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood1993; 81: 2767–73.
19.
ClaussMGerlachMGerlachHVascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med1990; 172: 1535–45.
20.
LevyAPTamargoRBremHNathansD.An endothelial cell growth factor from the mouse neuroblastoma cell line NB41. Growth Factors1989; 2: 9–19.
TakeshitaSZhengLPBrogiETherapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest1994; 93: 662–70.
23.
TakeshitaSPuLQSteinLAIntramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation1994; 90 (Part 2): II-228–II-234.
24.
BautersCAsaharaTZhengLPSite-specific therapeutic angiogenesis following systemic administration of vascular endothelial growth factor. J Vasc Surg21: 1995; 314–25.
25.
BautersCAsaharaTZhengLPPhysiologic assessment of augmented vascularity induced by VEGF in rabbit ischemic hindlimb. Am J Physiol1994; 36: H1263–H1271.
26.
SellkeFWQuillenJEBrooksLAHarrisonDG. Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation1990; 81: 1938–47.
27.
SellkeFWHaradaKWangSYBasic-fibroblast growth factor preserves endothelial function in the microcirculation perfused by collaterals [Abstract]. Abstracts of the Scientific Conference on the Molecular Cellular Biology of the Vascular Wall, Boston, MA, 1993 October 15–17.
28.
BautersCAsaharaTZhengLPRecovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb following administration of vascular endothelial growth factor. Circulation1995; 91: 2802–809.
29.
LosordoDWPickeringJGTakeshitaSUse of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo: Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation1994; 89: 785–92.
30.
RiessenRRahimizadehHBlessingETakeshitaSBarryJJIsnerJM. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther1993; 4: 749–58.
31.
TakeshitaSWeirLZhengLPTherapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Proc Natl Acad Sci USA1995 (in press).
32.
FerraraNHouckKAJakemanLBWinerJLeungDW. The vascular endothelial growth factor family of polypeptides. J Cell Biochem1991; 47: 211–18.
33.
D'AmorePAThompsonRW. Mechanisms of angiogenesis. Annu Rev Physiol1987; 49: 453–64.
34.
SengerDRPerruzziCAFederJDvorakHF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res1986; 46: 5629–32.
35.
SengerDRGalliSJDvorakAMPerruzziCAHarveyVSDvorakHF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science1983; 219: 983–85.
36.
DvorakHFSioussatTMBrownLFDistribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exp Med1991; 174: 1275–78.
SholleyMMFergusonGPSeibelHRMontourJLWilsonJD. Mechanisms of neovascularization: Vascular sprouting can occur without proliferation of endothelial cells. Lab Invest1984; 51: 624–34.
39.
NicosiaRFBonannoESmithM.Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J Cell Physiol1993; 154: 654–61.
40.
SchaperJWeibrauchD.Collateral vessel development in the porcine and canine heart. In: SchaperWSchaperJ eds. Collateral circulation: Heart, brain, kidney, limbs. Boston: Kluwer, 1993: 65–102.
41.
SchaperWde BrabanderMLewiP.DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res1971; 28: 671–79.
42.
PasykSSchaperWShaperJPasykKMiskiewiczGSteinseiferB.DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog. Am J Physiol1982; 242: H1031–H1037.
43.
CowanDFHollenbergNKConnellyCMWilliamsDHAbramsHL. Increased collateral arterial and venous endothelial cell turnover after renal artery stenosis in the dog. Invest Radiol1978; 13: 143–49.
44.
IlichNHollenbergNKWilliamsDHAbramsH.Time course of increased collateral arterial and venous endothelial cell turnover after renal artery stenosis in rat. Circ Res1979; 45: 579–82.
45.
WhiteFCCarrollSMMagnetABloorCM. Coronary collateral development in swine after coronary artery occlusion. Circ Res1992; 71: 1490–500.
46.
SchaperWSchaperJXhonneuxRVandesteeneR.The morphology of intercoronary anastomoses in chronic coronary artery occlusion. Cardiovasc Res1969; 3: 315–23.
47.
GrahamAMBaffourRBurdonTA demonstration of vascular proliferation in response to arteriovenous reversal in the ischemic canine hind limb. J Surg Res1989; 47: 341–47.
48.
SymesJFGrahamAMSteinLSnidermanAD. Salvage of a severely ischemic limb by arteriovenous revascularization: A case report. Can J Surg1984; 27: 274–76.
49.
UngerEFBanaiSShouMBasic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol1994; 266: H1588–H1595.
50.
TakeshitaSKearneyMLoushinCIn vivo evidence that vascular endothelial growth factor stimulates collateral formation by inducing arterial cell proliferation in a rabbit ischemic hindlimb [Abstract]. J Am Coll Cardiol1994; 23: 294A.
51.
DvorakHF. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med1986; 315: 1650–59.
52.
HerbertJMLamarcheIPrabonnaudVDolFGauthierT.Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J Biol Chem1994; 269: 3076–80.
53.
PepperMSFerraraNOrciLMontesanoR.Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor type 1 in microvascular endothelial cells. Biochem Biophys Res Commun1994; 189: 824–31.
54.
RossRGlomsetBKariyaBHarkerL.A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA1974; 71: 1207–210.
55.
CollinsTGinsbergDBossJMOrkinSHPoberJS. Cultured human endothelial cells express platelet-derived growth factor B chain: Cdna cloning and structural analysis. Nature1985; 316: 748–50.
56.
CollinsTPoberJSGimbroneMAJr.BetsholtzCWestermarkBHeldinC-H.Cultured human endothelial cells express platelet-derived factor A chain. Am J Pathol1987; 126: 7–12.
57.
ZerwesH-GRisauW.Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro. J Cell Biol1987; 105: 2037–41.
RobertsABSpornMBAssoianRKTransforming growth factor type-beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA1986; 83: 4167–71.
60.
RisauWDrexlerHMironovVPlatelet-derived growth factor is angiogenic in vivo. Growth Factors1992; 7: 261–66.
61.
LindnerVLappiDABairdRAMajackRAReidyMA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res1991; 68: 106–13.
62.
LindnerVReidyMA. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. Circ Res1993; 73: 589–95.
63.
BeitzJGKimISCalabresiPFrackeltonAR. Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci USA1991; 88: 2021–25.
BarRSBoesMBoothBADakeBLHenleySHartMN. The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology1989; 124: 2021–25.
66.
D'AmorePSmithSR. Growth factor effects on cells of the vascular wall: A survey. Growth Factors1993; 8: 61–75.
67.
PierceGFTarpleyJEYanagiharaDMustoeTEFoxGMThomasonA.Platelet derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Am J Pathol1992; 140: 1375–88.
68.
SimsDE. The pericyte – a review. Tissue Cell1986; 18: 153–74.
69.
SundbergCLjungstromMLindmarkGGerdinBRubinK.Microvascular pericytes express platelet-derived growth factor-β receptors in human healing wounds and colorectal adenocarcinoma. Am J Pathol1993; 143: 1377–88.
70.
SatoNBeitzJGKatoJPlatelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol1993; 142: 1119–39.
PepperMSVassalliJDOrciLMontesanoR.Biphasic effect of transforming growth factor-β 1 on in vitro angiogenesis. Exp Cell Res1993; 204: 356–63.
73.
ChenJKHoshiHMcKeehanWL. Transforming growth factor type β specifically stimulates synthesis of proteoglycans in human adult arterial smooth muscle cells. Proc Natl Acad Sci USA1987; 84: 5287–91.
74.
MadriJAPrattBMTuckerAM. Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix. J Cell Biol1993; 106: 1375–84.
75.
WinklesJAGayCG. Serum, phorbol ester, and polypeptide mitogens increase class 1 and 2 heparin binding (acidic and basic fibroblast growth factor) gene expression in human vascular smooth muscle cells. Cell Growth Differ1991; 2: 531–40.
76.
ShweikiDItinASofferDKeshetE.Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Science1992; 359: 843–45.
77.
TischerEMitchellRHartmanTThe human gene for vascular endothelial growth factor. J Biol Chem1991; 266: 11947–954.
78.
WangGLSemenzaGL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. Blood1993; 268: 21513–518.
79.
GotoFGotoKWeindelKFolkmanJ.Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation of bovine capillary endothelial cells within collagen gels. Lab Invest1993; 69: 508–17.
80.
AsaharaTBautersCPastoreCJLocal delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation1995; 91: 2793–801.
81.
AsaharaTBautersCPastoreCJSynergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation1995 (in press).
82.
KlagsbrunMFolkmanJ.Angiogenesis. In: SpornMBRobertsAB eds. Peptide growth factors and their receptors II. New York: Springer-Verlag, 1990: 459–586.
83.
WiltingJChristBBokelohMWeichHA. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res1993; 68: 106–13.
84.
KlagsbrunMBairdA.A duel receptor system is required for basic fibroblast growth factor activity. Cell1991; 67: 229–31.
85.
ParkJEChenHHWinerJHouckKAFerraraN.Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem1994; 269: 25646–654.
86.
IsnerJMWalshKSymesJArterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation1995; 91: 2687–92.
87.
FischerMMeadowsM-EDoTDelayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent cerebral ischemia in rats. J Cereb Blood Flow Metab1995 (in press).